David Goel’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,000,000
Closed -$45.9M 22
2022
Q1
$45.9M Buy
+1,000,000
New +$47.7M 0.55% 22

Other funds holding ARKG

David Goel's ARKG Position: Q2 2022 in Review

David Goel sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2022, closing a stake of 1,000,000 shares — an estimated $45.9M sold.

David Goel first reported a position in ARKG in Q1 2022 and held it in 1 quarter. The position peaked at $45.9M in Q1 2022. 334 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.

  • David Goel reported no remaining ARK Genomic Revolution ETF position as of Q2 2022 after selling out during the quarter.
  • David Goel sold 1,000,000 ARK Genomic Revolution ETF shares in Q2 2022, an estimated $45.9M.
  • David Goel first reported a position in ARK Genomic Revolution ETF in Q1 2022 and held it in 1 quarter.
  • David Goel's ARK Genomic Revolution ETF position peaked at $45.9M in Q1 2022.
  • 334 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.

Based on Matrix Capital Management Company's 13F filing for Q2 2022, filed 15 Aug 2022.